Literature DB >> 31828503

A retrospective case control study identifies peripheral blood mononuclear cell albumin RNA expression as a biomarker for non-alcoholic fatty liver disease.

Xin Chu1, Kelsey Karasinski2, Sean Donellan2, Scott Kaniper2, G Craig Wood1, Weixing Shi1, Michael A Edwards3, Rohit Soans3, Christopher D Still1, Glenn S Gerhard4.   

Abstract

PURPOSE: Non-alcoholic fatty liver disease (NAFLD) improves after bariatric surgery. The aim of this study was to determine whether peripheral blood mononuclear cell albumin gene expression was related to NAFLD and whether albumin (ALB) and alpha fetoprotein (AFP) expression could be detected in whole blood and visceral adipose tissue.
METHODS: Using a retrospective case control study design, RNA isolated from peripheral blood mononuclear cells from patients prior to undergoing bariatric surgery was used for pooled microarray analysis. Quantitative polymerase chain reaction (QPCR) was used to analyze whole blood and visceral adipose tissue. Liver histology was obtained via intra-operative biopsy and clinical data extracted from the electronic health record.
RESULTS: The albumin (ALB) gene was the second most up-regulated found in microarray analysis of peripheral blood mononuclear cell RNA from patients with hepatic lobular inflammation versus normal liver histology. Transcript levels of ALB were significantly different across those with normal (n = 50), steatosis (n = 50), lobular inflammation (n = 50), and peri-sinusoidal fibrosis (n = 50) liver histologies, with lobular inflammation 3.9 times higher than those with normal histology (p < 0.017). Albumin expression levels decreased in 11/13 patients in paired samples obtained prior to and at 1 year after Roux-en-Y gastric bypass surgery. ALB expression could be detected in 23 visceral adipose tissue samples obtained intra-operatively and in 18/19 available paired whole blood samples. No significant correlation was found between ALB expression in visceral adipose tissue and whole blood RNA samples. Alpha fetoprotein expression as a marker of early hepatocytic differentiation was detected in 17/17 available VAT RNA samples, but in only 2/17 whole blood RNA samples.
CONCLUSION: Albumin RNA expression from blood cells may serve as a biomarker of NAFLD. Albumin and alpha fetoprotein appear to be ubiquitously expressed in visceral adipose tissue in patients with extreme obesity.

Entities:  

Keywords:  Albumin; Bariatric surgery; Extreme obesity; NAFLD

Mesh:

Substances:

Year:  2019        PMID: 31828503      PMCID: PMC7435277          DOI: 10.1007/s00423-019-01848-0

Source DB:  PubMed          Journal:  Langenbecks Arch Surg        ISSN: 1435-2443            Impact factor:   3.445


  56 in total

1.  Bariatric surgery acutely changes the expression of inflammatory and lipogenic genes in obese adipose tissue.

Authors:  Francisco J Ortega; Ramon Vilallonga; Gemma Xifra; Mònica Sabater; Wifredo Ricart; José M Fernández-Real
Journal:  Surg Obes Relat Dis       Date:  2015-08-24       Impact factor: 4.734

2.  Effect of bariatric surgery on liver fibrosis.

Authors:  Myriam Moretto; Carlos Kupski; Vinicius Duval da Silva; Alexandre V Padoin; Cláudio C Mottin
Journal:  Obes Surg       Date:  2012-07       Impact factor: 4.129

3.  Prospective study of the long-term effects of bariatric surgery on liver injury in patients without advanced disease.

Authors:  Philippe Mathurin; Antoine Hollebecque; Laurent Arnalsteen; David Buob; Emmanuelle Leteurtre; Robert Caiazzo; Marie Pigeyre; Hélène Verkindt; Sébastien Dharancy; Alexandre Louvet; Monique Romon; François Pattou
Journal:  Gastroenterology       Date:  2009-05-04       Impact factor: 22.682

Review 4.  Update on the mechanisms of homing of adipose tissue-derived stem cells.

Authors:  Yong Zhao; Haiyang Zhang
Journal:  Cytotherapy       Date:  2016-07       Impact factor: 5.414

5.  Nonalcoholic fatty liver disease: Improvement in liver histological analysis with weight loss.

Authors:  John B Dixon; Prithi S Bhathal; Norman R Hughes; Paul E O'Brien
Journal:  Hepatology       Date:  2004-06       Impact factor: 17.425

6.  Bariatric surgery improves nonalcoholic fatty liver disease: a contemporary systematic review and meta-analysis.

Authors:  Tannous K Fakhry; Rahul Mhaskar; Theresa Schwitalla; Elnara Muradova; John Paul Gonzalvo; Michel M Murr
Journal:  Surg Obes Relat Dis       Date:  2018-12-06       Impact factor: 4.734

7.  Nonalcoholic steatohepatitis is the most rapidly growing indication for liver transplantation in patients with hepatocellular carcinoma in the U.S.

Authors:  Robert J Wong; Ramsey Cheung; Aijaz Ahmed
Journal:  Hepatology       Date:  2014-04-25       Impact factor: 17.425

Review 8.  Human Adipose Stem Cells: From Bench to Bedside.

Authors:  Francesco De Francesco; Giulia Ricci; Francesco D'Andrea; Giovanni Francesco Nicoletti; Giuseppe Andrea Ferraro
Journal:  Tissue Eng Part B Rev       Date:  2015-06-17       Impact factor: 6.389

Review 9.  Current understanding of adipose-derived mesenchymal stem cell-based therapies in liver diseases.

Authors:  Chenxia Hu; Lingfei Zhao; Lanjuan Li
Journal:  Stem Cell Res Ther       Date:  2019-07-08       Impact factor: 6.832

10.  Gene expression profiling in subcutaneous, visceral and epigastric adipose tissues of patients with extreme obesity.

Authors:  G S Gerhard; A M Styer; W E Strodel; S L Roesch; A Yavorek; D J Carey; G C Wood; A T Petrick; J Gabrielsen; A Ibele; P Benotti; D D Rolston; C D Still; G Argyropoulos
Journal:  Int J Obes (Lond)       Date:  2013-08-16       Impact factor: 5.095

View more
  1 in total

1.  Development and Validation of a Novel Scoring System for Noninvasive Nonalcoholic Steatohepatitis Detection in Bariatric Patients.

Authors:  Adrian T Billeter; Sarah Wloka; Rouven Behnisch; Thomas Albrecht; Stephanie Roessler; Benjamin Goeppert; Sebastian Mueller; Felix Nickel; Beat Müller
Journal:  Obes Facts       Date:  2021-08-20       Impact factor: 3.942

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.